228 related articles for article (PubMed ID: 21255635)
1. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions.
Chen L; Liu J; Ali U; Gui ZH; Hou C; Fan LL; Wang Y; Wang T
Brain Res Bull; 2011 Feb; 84(3):215-23. PubMed ID: 21255635
[TBL] [Abstract][Full Text] [Related]
2. Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats.
Chen L; Liu J; Zhang QJ; Feng JJ; Gui ZH; Ali U; Wang Y; Fan LL; Hou C; Wang T
Brain Res Bull; 2011 Jul; 85(6):329-38. PubMed ID: 21624440
[TBL] [Abstract][Full Text] [Related]
3. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
Chen L; Zhang QJ; Liu J; Wang S; Ali U; Gui ZH; Wang Y
Brain Res; 2009 Aug; 1286():192-200. PubMed ID: 19545547
[TBL] [Abstract][Full Text] [Related]
4. Blockade of mGluR5 reverses abnormal firing of subthalamic nucleus neurons in 6-hydroxydopamine partially lesioned rats.
Chen L; Liu J; Ali U; Gui ZH; Wang Y; Wang T; Hou C; Fan LL
Chin J Physiol; 2011 Oct; 54(5):303-9. PubMed ID: 22135908
[TBL] [Abstract][Full Text] [Related]
5. [Effects of chronic, systemic treatment with metabotropic glutamate receptor 5 antagonist on behavioral activity and neuroprotection in a preclinical rat model of Parkinson's disease].
Chen L; Liu J; Gui ZH; Wang Y; Xiang L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):65-8. PubMed ID: 21355304
[TBL] [Abstract][Full Text] [Related]
6. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH
Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665
[TBL] [Abstract][Full Text] [Related]
7. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.
Ambrosi G; Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
Brain Res Bull; 2010 Apr; 82(1-2):29-38. PubMed ID: 20100549
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease.
Vernon AC; Palmer S; Datla KP; Zbarsky V; Croucher MJ; Dexter DT
Eur J Neurosci; 2005 Oct; 22(7):1799-806. PubMed ID: 16197521
[TBL] [Abstract][Full Text] [Related]
9. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
Sun YN; Wang T; Wang Y; Han LN; Li LB; Zhang YM; Liu J
Neuropharmacology; 2015 Aug; 95():181-91. PubMed ID: 25797491
[TBL] [Abstract][Full Text] [Related]
10. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
Oueslati A; Breysse N; Amalric M; Kerkerian-Le Goff L; Salin P
Eur J Neurosci; 2005 Dec; 22(11):2765-74. PubMed ID: 16324110
[TBL] [Abstract][Full Text] [Related]
11. The selective 5-HT(1A) receptor antagonist WAY-100635 increases neuronal activity of the basolateral nucleus of the amygdala in 6-hydroxydopamine-lesioned rats.
Zhang QJ; Wu ZH; Liu J; Wang T; Wang S; Han LN
Sheng Li Xue Bao; 2008 Apr; 60(2):259-69. PubMed ID: 18425316
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease.
Domenici MR; Potenza RL; Martire A; Coccurello R; Pèzzola A; Reggio R; Tebano MT; Popoli P
J Neurosci Res; 2005 Jun; 80(5):646-54. PubMed ID: 15880742
[TBL] [Abstract][Full Text] [Related]
13. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
[TBL] [Abstract][Full Text] [Related]
14. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
[TBL] [Abstract][Full Text] [Related]
15. In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.
Chen MT; Morales M; Woodward DJ; Hoffer BJ; Janak PH
Exp Neurol; 2001 Sep; 171(1):72-83. PubMed ID: 11520122
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease.
De Leonibus E; Managò F; Giordani F; Petrosino F; Lopez S; Oliverio A; Amalric M; Mele A
Neuropsychopharmacology; 2009 Feb; 34(3):729-38. PubMed ID: 18704096
[TBL] [Abstract][Full Text] [Related]
17. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wu ZH; Li Q
Brain Res; 2010 Jan; 1310():189-99. PubMed ID: 19896932
[TBL] [Abstract][Full Text] [Related]
18. Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease.
Phillips JM; Lam HA; Ackerson LC; Maidment NT
Eur J Neurosci; 2006 Jan; 23(1):151-60. PubMed ID: 16420425
[TBL] [Abstract][Full Text] [Related]
19. Changes in the firing activity of serotonergic neurons in the dorsal raphe nucleus in a rat model of Parkinson's disease.
Zhang QJ; Gao R; Liu J; Liu YP; Wang S
Sheng Li Xue Bao; 2007 Apr; 59(2):183-9. PubMed ID: 17437041
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease.
Leaver KR; Allbutt HN; Creber NJ; Kassiou M; Henderson JM
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1388-94. PubMed ID: 18785982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
